1. Pink Sheet

US FDA User Fee Staffing: The Objective Capacity Planning Adjuster Often Needs Subjective Review

 
• By Derrick Gingery

The FDA has overruled the results from its own formula intended to match resource levels with workload every time except once.

workforce management
The capacity planning adjustment has the CBER number of employees about right for drug review activities. • Source: Shutterstock

The drug review program at the US Food and Drug Administration can operate with fewer employees today than three years ago, but according the the agency’s own calculations, the number of staff that FDA needs to add to reach the ideal total is still viewed as largely unattainable.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from US FDA

More from Agency Leadership